skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: tipo de recurso: Artigos remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Industrial apiculture in the Jordan valley during Biblical times with Anatolian honeybees
Industrial apiculture in the Jordan valley during Biblical times with Anatolian honeybees
Material Type:
Artigo 		Adicionar ao Meu Espaço

Industrial apiculture in the Jordan valley during Biblical times with Anatolian honeybees

Guy Bloch Tiago Maurício Francoy; Ido Wachtel; Nava Panitz-Cohen; Stefan Fuchs; Amihai Mazar

Proceedings of the National Academy of Sciences of the United States of America Washington v. 107, n. 25, p. 11240-11244, jun. 2010

Washington 2010

Item não circula. Consulte sua biblioteca.(Acessar)

2
PET in vivo generators 134Ce and 140Nd on an internalizing monoclonal antibody probe
PET in vivo generators 134Ce and 140Nd on an internalizing monoclonal antibody probe
Material Type:
Artigo 		Adicionar ao Meu Espaço

PET in vivo generators 134Ce and 140Nd on an internalizing monoclonal antibody probe

Severin, G. W. ; Fonslet, J. ; Kristensen, L. K. ; Nielsen, C. H. ; Jensen, A. I. ; Kjær, A. ; Mazar, A. P. ; Johnston, K. ; Köster, U.

Scientific reports, 2022-03, Vol.12 (1), p.3863-3863, Article 3863 [Periódico revisado por pares]

London: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
9-ING-41, a clinically relevant inhibitor of glycogen synthase kinase-3 (GSK-3), is active pre-clinically in human bladder and renal cell cancers
9-ING-41, a clinically relevant inhibitor of glycogen synthase kinase-3 (GSK-3), is active pre-clinically in human bladder and renal cell cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

9-ING-41, a clinically relevant inhibitor of glycogen synthase kinase-3 (GSK-3), is active pre-clinically in human bladder and renal cell cancers

Kuroki, H. ; Anraku, T. ; Bilim, V. ; Tasaki, M. ; Schmitt, D. ; Mazar, A. ; Ugolkov, A. ; Tomita, Y.

Annals of oncology, 2018-10, Vol.29, p.viii9-viii9 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Preclinical uPAR-targeted multimodal imaging of locoregional oral cancer
Preclinical uPAR-targeted multimodal imaging of locoregional oral cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Preclinical uPAR-targeted multimodal imaging of locoregional oral cancer

Boonstra, M.C ; Van Driel, P.B.A.A ; Keereweer, S ; Prevoo, H.A.J.M ; Stammes, M.A ; Baart, V.M ; Löwik, C.W.G.M ; Mazar, A.P ; van de Velde, C.J.H ; Vahrmeijer, A.L ; Sier, C.F.M

Oral oncology, 2017-03, Vol.66, p.1-8 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH ), a beta integrin antagonist, in patients with solid tumours
Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH ), a beta integrin antagonist, in patients with solid tumours
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH ), a beta integrin antagonist, in patients with solid tumours

Cianfrocca, M E ; Kimmel, K A ; Gallo, J ; Cardoso, T ; Brown, M M ; Hudes, G ; Lewis, N ; Weiner, L ; Lam, G N ; Brown, S C ; Shaw, D E ; Mazar, A P ; Cohen, R B

British journal of cancer, 2006-06, Vol.94 (11), p.1621-1626 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)
Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)

Doñate, F ; Juarez, J C ; Burnett, M E ; Manuia, M M ; Guan, X ; Shaw, D E ; Smith, E L P ; Timucin, C ; Braunstein, M J ; Batuman, O A ; Mazar, A P

British journal of cancer, 2008-02, Vol.98 (4), p.776-783 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
GSK‐3ß INHIBITOR, 9‐ING‐41 REDUCES CELL VIABILITY AND HALTS PROLIFERATION OF B‐CELL LYMPHOMA
GSK‐3ß INHIBITOR, 9‐ING‐41 REDUCES CELL VIABILITY AND HALTS PROLIFERATION OF B‐CELL LYMPHOMA
Material Type:
Artigo 		Adicionar ao Meu Espaço

GSK‐3ß INHIBITOR, 9‐ING‐41 REDUCES CELL VIABILITY AND HALTS PROLIFERATION OF B‐CELL LYMPHOMA

Karmali, R. ; Chukkapalli, V. ; Pro, B. ; Borgia, J.A. ; Mazar, A. ; Ugolkov, A. ; Giles, F.J.

Hematological oncology, 2017-06, Vol.35 (S2), p.400-402 [Periódico revisado por pares]

Chichester: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
8
The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer
The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer

Mazar, Andrew P

Anti-cancer drugs, 2001-06, Vol.12 (5), p.387-400 [Periódico revisado por pares]

England: Lippincott Williams & Wilkins, Inc

Texto completo disponível

Citações Citado por
9
The Role of the Plasminogen Activation System in Angiogenesis and Metastasis
The Role of the Plasminogen Activation System in Angiogenesis and Metastasis
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Role of the Plasminogen Activation System in Angiogenesis and Metastasis

Rabbani, Shafaat A. ; Mazar, Andrew P.

Surgical oncology clinics of North America, 2001-04, Vol.10 (2), p.393-415 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
10
The urokinase plasminogen activator system in cancer : Implications for tumor angiogenesis and metastasis
The urokinase plasminogen activator system in cancer : Implications for tumor angiogenesis and metastasis
Material Type:
Artigo 		Adicionar ao Meu Espaço

The urokinase plasminogen activator system in cancer : Implications for tumor angiogenesis and metastasis

MAZAR, A. P ; HENKIN, J ; GOLDFARB, R. H

Angiogenesis (London), 1999, Vol.3 (1), p.15-32 [Periódico revisado por pares]

Dordrecht: Springer

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (141)
  2. Revistas revisadas por pares (123)

Data de Publicação 

De até
Refinar
  1. Antes de1984  (10)
  2. 1984Até1991  (21)
  3. 1992Até1999  (38)
  4. 2000Até2010  (53)
  5. Após 2010  (20)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (138)
  2. Japonês  (17)
  3. Francês  (2)
  4. Persa  (1)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.